biotech / news / / Markets Insider
Currently, the analyst consensus on Hansoh Pharmaceutical Group Company Limited is a Strong Buy with an average price target of HK$46.14.
Morgan Stanley set a new price target of HK$45.00 for Hansoh Pharmaceutical shares.
KEY POINTS
- Hansoh Pharmaceutical shares last closed at HK$39.90, below the new price target.
- The analyst consensus rates Hansoh Pharmaceutical Group as a Strong Buy with a HK$46.14 target.
- Hansoh reported Q2 revenue of HK$7.43 billion and net profit of HK$3.13 billion, both up year-over-year.
COMPANIES
Summarized by Newsio from Markets Insider. How we summarize →